TY - JOUR
T1 - Pathological characteristics of prostate cancer in men aged < 50 years treated with radical prostatectomy
T2 - A multi-centre study in Korea
AU - Chung, Mun Su
AU - Shim, Myungsun
AU - Cho, Jin Seon
AU - Bang, Woojin
AU - Kim, Sun Il
AU - Cho, Sung Yong
AU - Rha, Koon Ho
AU - Hong, Sung Joon
AU - Koo, Kyo Chul
AU - Lee, Kwang Suk
AU - Chung, Byung Ha
AU - Lee, Seung Hwan
N1 - Publisher Copyright:
© 2019 The Korean Academy of Medical Sciences.
PY - 2019/3/18
Y1 - 2019/3/18
N2 - Background: Recently, younger prostate cancer (PCa) patients have been reported to harbour more favourable disease characteristics after radical prostatectomy (RP) than older men. We analysed young men (<50 years) with PCa among the Korean population, paying attention to pathological characteristics on RP specimen and biochemical recurrence (BCR). Methods: The multi-centre, Severance Urological Oncology Group registry was utilized to identify 622 patients with clinically localized or locally advanced PCa, who were treated with RP between 2001 and 2017. Patients were dichotomized into two groups according to age (< 50-year-old [n = 75] and = 50-year-old [n = 547]), and clinicopathological characteristics were analysed. Propensity score matching was used when assessing BCR between the two groups. Results: Although biopsy Gleason score (GS) was lower in younger patients (P = 0.033), distribution of pathologic GS was similar between the two groups (13.3% vs. 13.9% for GS = 8, P = 0.191). There was no significant difference in pathologic T stage between the < 50- and = 50-year-old groups (69.3% vs. 68.0% in T2 and 30.7% vs. 32.0% in = T3, P = 0.203). The positive surgical margin rates were similar between the two groups (20.0% vs. 27.6%, P = 0.178). BCR-free survival rates were also similar (P = 0.644) between the two groups, after propensity matching. Conclusion: Contrary to prior reports, younger PCa patients did not have more favourable pathologic features on RP specimen and showed similar BCR rates compared to older men. These findings should be considered when making treatment decisions for young Korean patients with PCa.
AB - Background: Recently, younger prostate cancer (PCa) patients have been reported to harbour more favourable disease characteristics after radical prostatectomy (RP) than older men. We analysed young men (<50 years) with PCa among the Korean population, paying attention to pathological characteristics on RP specimen and biochemical recurrence (BCR). Methods: The multi-centre, Severance Urological Oncology Group registry was utilized to identify 622 patients with clinically localized or locally advanced PCa, who were treated with RP between 2001 and 2017. Patients were dichotomized into two groups according to age (< 50-year-old [n = 75] and = 50-year-old [n = 547]), and clinicopathological characteristics were analysed. Propensity score matching was used when assessing BCR between the two groups. Results: Although biopsy Gleason score (GS) was lower in younger patients (P = 0.033), distribution of pathologic GS was similar between the two groups (13.3% vs. 13.9% for GS = 8, P = 0.191). There was no significant difference in pathologic T stage between the < 50- and = 50-year-old groups (69.3% vs. 68.0% in T2 and 30.7% vs. 32.0% in = T3, P = 0.203). The positive surgical margin rates were similar between the two groups (20.0% vs. 27.6%, P = 0.178). BCR-free survival rates were also similar (P = 0.644) between the two groups, after propensity matching. Conclusion: Contrary to prior reports, younger PCa patients did not have more favourable pathologic features on RP specimen and showed similar BCR rates compared to older men. These findings should be considered when making treatment decisions for young Korean patients with PCa.
UR - http://www.scopus.com/inward/record.url?scp=85063280543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063280543&partnerID=8YFLogxK
U2 - 10.3346/jkms.2019.34.e78
DO - 10.3346/jkms.2019.34.e78
M3 - Article
C2 - 30886549
AN - SCOPUS:85063280543
SN - 1011-8934
VL - 34
JO - Journal of Korean Medical Science
JF - Journal of Korean Medical Science
IS - 10
M1 - e78
ER -